Morphoceuticals Inc.

About Morphoceuticals Inc.

Morphoceuticals is a TechBio company focused on building the first atlas of the bioelectrome, a communication network within the body that maintains tissue and organ integrity. Their mission is to understand and manipulate bioelectric patterns to induce regeneration and treat diseases, potentially enabling tissue repair and organ regeneration using AI-driven technology and multi-omics.

Products & Services

Bioelectrome Atlas:A project to map the bioelectrome, the body's communication networks, to facilitate tissue repair and regeneration.

AI-Driven Bioelectric Modulation:Technology using AI to modulate ion channels for bioelectric signaling, aiming to enable novel health discoveries.

Specialties

Bioelectrome Mapping Regenerative Medicine AI-Driven Technology Bioelectric Signaling Multi-Omics

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed 2 T: - FT: Seed 2	A: 8000000 MR: - FA: 8 million FAN: 8000000	D: 2023-02-15 FD: 2023-02-15	2 investors

Seed 2 Latest

2023-02-15

$8.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jim Jenson

Chief Executive Officer

R

Roger Pomerantz

Chairman of the Board of Directors

M

Michael Levin

Scientific Co-Founder

D

David Kaplan

Scientific Co-Founder

N

Nicolas Palacios-Prado

Director of Technology Development

M

Meisam Bagheri

Scientist

View 11 more team members with Pro

Unlock Full Team Directory

Recent News